Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in Canada
Model projections suggest RF RDN, under assumed maintained treatment effect, is a cost-effective treatment strategy for uncontrolled hypertension in the Canadian healthcare system based on meaningful reductions in clinical events.
Authors
- Hamid Sadri (ORCID: https://orcid.org/0000-0003-2004-7060)
- Lindsay Machan
- Sheldon W. Tobe (ORCID: https://orcid.org/0000-0001-7848-3872)
- Ernesto L. Schiffrin (ORCID: https://orcid.org/0000-0002-4502-2823)
- Jan B. Pietzsch (ORCID: https://orcid.org/0000-0002-5078-1939)
- George K. Dresser (ORCID: https://orcid.org/0000-0002-3604-6743)
- Khoa N. Cao (ORCID: https://orcid.org/0000-0002-2834-1072)
- Phil McFarlane (ORCID: https://orcid.org/0000-0003-2935-9618)
- Mina Madan (ORCID: https://orcid.org/0000-0003-0285-6569)
- Raj Padwal (ORCID: https://orcid.org/0000-0003-3541-2817)
- Ross D. Feldman (ORCID: https://orcid.org/0000-0001-9880-0484)
- Anne M. Ryschon
Institutions
- Western University (CA)
- St. Michael's Hospital (CA)
- Sunnybrook Health Science Centre (CA)
- University of British Columbia (CA)
- University of Alberta (CA)
- University of Toronto (CA)
- Jewish General Hospital (CA)
- Health Sciences Centre (CA)
- Medtronic (Ireland) (IE)
- Health Economics and Outcomes Research (United Kingdom) (GB)
- Medtronic (Canada) (CA)
- McGill University (CA)
- NOSM University (CA)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1080/13696998.2024.2441072
- Citations
- 4
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.61